Endocrine Disruption

Endocrine disruption has been recognized as a priority endpoint in safety evaluation of chemicals and consumer products.


Category

Visit the Endocrine Disruption shop

Endocrine disruption has been recognized as a priority endpoint in safety evaluation of chemicals and consumer products. Endocrine disrupting compounds (EDCs) are being classified as substances of very high concern and regulations to restrict their use are being installed world-wide. EDC effects are hard to predict and are best tested using bioassays.

CALUX® methods Available for endocrine disruption screening

To avoid animal studies BDS has developed a range of assays that allow screening and safety assessment of chemicals and complex mixtures including consumer products in a rapid and cost-effective manner.

In vitro assays

SaferWorlbyDesign provides In vitro testing/assays on compounds and formulations for the cosmetics, pharma, medical device, chemical, and food industries.

More

Tests and Services

SaferWorldbyDesign integrates in silico and in vitro methods to develop standard and premium Integrated Approaches to Testing and Assessment (IATAs), including methods that support ingredient and formulation screening and testing, product design and the preparation of Regulatory Dossiers.

More

Tissues and Fluids

Human skin samples, offered in our shop, are collected from patients who have undergone cosmetic surgery. We also offer additional services.

More

SaferWorldbyDesign

SaferWorldbyDesign integrates in silico and in vitro methods to develop standard and premium Integrated Approaches to Testing and Assessment (IATAs), including methods that support ingredient and formulation screening and testing, product design and the preparation of Regulatory Dossiers.


Disclaimer

Edelweiss Connect GmbH is registered as a limited company with Handelsregisteramt of Kanton Basel-Stadt

Swiss ID (UID) number: CHE-114.414.615

Copyright | SaferWorldbyDesign 2022